Epirubicin Hydrochloride Injection 50mg in 25 mL (13)

Valsts: Austrālija

Valoda: angļu

Klimata pārmaiņas: Department of Health (Therapeutic Goods Administration)

Aktīvā sastāvdaļa:

epirubicin hydrochloride, Quantity: 2 mg/mL

Pieejams no:

Pfizer (Perth) Pty Ltd

Zāļu forma:

Injection, solution

Kompozīcija:

Excipient Ingredients: sodium chloride; hydrochloric acid; water for injections

Ievadīšanas:

Intravenous Infusion, Intravesical

Vienības iepakojumā:

1 x 25 mL

Receptes veids:

(S1) This Schedule is intentionally blank

Ārstēšanas norādes:

Farmorubicin has been shown to be particularly effective in the treatment of breast, ovarian, stomach, colon and lung cancers. Furthermore, Farmorubicin may be used in the treatment of cancer of the blood-forming organs such as malignant lymphomas, leukaemia and multiple myeloma. Farmorubicin may also be injected directly through a tube into the urinary bladder. This method is sometimes used in the treatment of cell abnormalities or bladder wall cancer.

Produktu pārskats:

Visual Identification: Red coloured clear solution; Container Type: Vial; Container Material: PP; Container Life Time: 36 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Autorizācija statuss:

Listed (Export Only)

Autorizācija datums:

2019-02-27